195 related articles for article (PubMed ID: 15284532)
1. Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver.
Girard H; Court MH; Bernard O; Fortier LC; Villeneuve L; Hao Q; Greenblatt DJ; von Moltke LL; Perussed L; Guillemette C
Pharmacogenetics; 2004 Aug; 14(8):501-15. PubMed ID: 15284532
[TBL] [Abstract][Full Text] [Related]
2. Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs.
Villeneuve L; Girard H; Fortier LC; Gagné JF; Guillemette C
J Pharmacol Exp Ther; 2003 Oct; 307(1):117-28. PubMed ID: 12944498
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 gene.
Olson KC; Dellinger RW; Zhong Q; Sun D; Amin S; Spratt TE; Lazarus P
Drug Metab Dispos; 2009 Oct; 37(10):1999-2007. PubMed ID: 19589876
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between common polymorphisms in UGT1A9 and gene expression and activity.
Ramírez J; Liu W; Mirkov S; Desai AA; Chen P; Das S; Innocenti F; Ratain MJ
Drug Metab Dispos; 2007 Dec; 35(12):2149-53. PubMed ID: 17761781
[TBL] [Abstract][Full Text] [Related]
5. The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients.
Kuypers DR; Naesens M; Vermeire S; Vanrenterghem Y
Clin Pharmacol Ther; 2005 Oct; 78(4):351-61. PubMed ID: 16198654
[TBL] [Abstract][Full Text] [Related]
6. Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population.
Jiang J; Zhang X; Huo R; Li X; Yang Y; Gai Z; Xu M; Shen L; Cai L; Wan C; Li B; He L; Qin S
Pharmacogenomics J; 2015 Aug; 15(4):326-31. PubMed ID: 25446781
[TBL] [Abstract][Full Text] [Related]
7. Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).
Takahashi H; Maruo Y; Mori A; Iwai M; Sato H; Takeuchi Y
Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):131-6. PubMed ID: 18816295
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations.
Mehlotra RK; Bockarie MJ; Zimmerman PA
Eur J Clin Pharmacol; 2007 Jan; 63(1):1-8. PubMed ID: 17115150
[TBL] [Abstract][Full Text] [Related]
9. C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation.
Baldelli S; Merlini S; Perico N; Nicastri A; Cortinovis M; Gotti E; Remuzzi G; Cattaneo D
Pharmacogenomics; 2007 Sep; 8(9):1127-41. PubMed ID: 17924828
[TBL] [Abstract][Full Text] [Related]
10. Three novel single nucleotide polymorphisms of UGT1A9 in a Thai population.
Korprasertthaworn P; Udomuksorn W; Yoovathaworn K
Drug Metab Pharmacokinet; 2009; 24(5):482-5. PubMed ID: 19881262
[TBL] [Abstract][Full Text] [Related]
11. Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphisms.
Street CM; Zhu Z; Finel M; Court MH
Xenobiotica; 2017 Jan; 47(1):1-10. PubMed ID: 26999266
[TBL] [Abstract][Full Text] [Related]
12. Circadian Clock Component Rev-erb
Xu H; Chen M; Yu F; Zhang T; Wu B
Drug Metab Dispos; 2020 Aug; 48(8):681-689. PubMed ID: 32527940
[TBL] [Abstract][Full Text] [Related]
13. Association analysis of UGT1A genotype and haplotype with SN-38 glucuronidation in human livers.
Wang H; Bian T; Jin T; Chen Y; Lin A; Chen C
Pharmacogenomics; 2014 Apr; 15(6):785-98. PubMed ID: 24897286
[TBL] [Abstract][Full Text] [Related]
14. Determination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidation.
Jarrar YB; Cha EY; Seo KA; Ghim JL; Kim HJ; Kim DH; Lee SJ; Shin JG
J Lipid Res; 2014 Nov; 55(11):2334-42. PubMed ID: 25249502
[TBL] [Abstract][Full Text] [Related]
15. Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.
Innocenti F; Grimsley C; Das S; Ramírez J; Cheng C; Kuttab-Boulos H; Ratain MJ; Di Rienzo A
Pharmacogenetics; 2002 Dec; 12(9):725-33. PubMed ID: 12464801
[TBL] [Abstract][Full Text] [Related]
16. Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells.
Nagar S; Zalatoris JJ; Blanchard RL
Pharmacogenetics; 2004 Aug; 14(8):487-99. PubMed ID: 15284531
[TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
18. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.
Court MH; Freytsis M; Wang X; Peter I; Guillemette C; Hazarika S; Duan SX; Greenblatt DJ; Lee WM;
J Pharmacol Exp Ther; 2013 May; 345(2):297-307. PubMed ID: 23408116
[TBL] [Abstract][Full Text] [Related]
19. UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients.
Fukuda T; Goebel J; Cox S; Maseck D; Zhang K; Sherbotie JR; Ellis EN; James LP; Ward RM; Vinks AA
Ther Drug Monit; 2012 Dec; 34(6):671-9. PubMed ID: 23131697
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymes.
Ramírez J; Iyer L; Journault K; Bélanger P; Innocenti F; Ratain MJ; Guillemette C
Pharm Res; 2002 May; 19(5):588-94. PubMed ID: 12069159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
